Key Sessions
Nathan Lewis, PhD
KEYNOTE: Engineering Out Metabolic Barriers in CHO Cells
University of California, San Diego
Nuno Fontes
Advances in process and manufacturing technology platforms for the industrialization of allogeneic cell therapy
Bayer U.S. LLC
Tiago Matos
Digital Transformation: Accelerating Process Development and Enhancing Control Strategies
Merck
Jacqualyn Schulman, Ph.D.
Engineering CHO Cells to improve a post-translational modification for a bispecific antibody production
Bristol-Myers Squibb
keyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
Main Conference Day 1 (Exhibit Hall Open 3:00-6:30pm) - PT (Pacific Time, GMT-08:00)
keyboard_arrow_leftSearch & Filter
search
Streams
Clear
Formats
Main Conference Day 1 (Exhibit Hall Open 3:00-6:30pm) - PT (Pacific Time, GMT-08:00)
search
Streams
Clear
Formats
Showing 2 of 2 Streams
Recovery & Purification
Manufacturing Strategy & Bioprocessing 4.0
10:25am - 10:30am
Chairperson's Remarks
- Ruben Carbonell - Director, William R. Kenan, Jr. Institute for Engineering, Technology & Science, Frank Hawkins Kenan Distinguished Professor of Chemical and Biomolecular Engineering, North Carolina State University
10:30am - 11:00am
Keynote Address: Fully Continuous purification platform using nanoparticles with ligands and ultrafiltration
- Irina Ramos - Director, Bioprocess Technology and Engineering, AstraZeneca
11:00am - 11:30am
A Review of Supports for Adsorptive Separations of Biomolecules
- Tom Ransohoff - Principal, RTI Consulting, LLC
11:30am - 12:00pm
Designing Purification Strategies for Bispecific Antibodies
- Alexandra Cabatingan - Bioprocess Resin Sales Specialist, Cytiva
10:25am - 10:55am
Please Move To Another Track
10:55am - 11:00am
Chairperson's Remarks
- Alanna Benamy - Manager, Member Engagement, Rx-360
11:00am - 11:30am
Plastics: A Biophorum Case Study
- Merete Miles - Sr. Director Environmental Sustainability, Thermo Fisher Scientific
11:30am - 12:00pm
Sustainability in Bioprocessing: A Pathway towards a Greener Future
- Adam Goldstein - Senior Director, R+D Collaborations, Thermo Fisher Scientific
Showing 2 of 2 Streams
Recovery & Purification
Manufacturing Strategy & Bioprocessing 4.0
1:25pm - 1:30pm
Chairperson's Remarks
- Tom Ransohoff - Principal, RTI Consulting, LLC
1:30pm - 2:00pm
Depth Filtration for the Removal of Host Cell Proteins
- Liang-Kai Chu - Ph.D. Candidate, Pennsylvania State University
2:00pm - 2:30pm
Use of Nonwoven Membranes for Process Chromatography
- Ruben Carbonell - Director, William R. Kenan, Jr. Institute for Engineering, Technology & Science, Frank Hawkins Kenan Distinguished Professor of Chemical and Biomolecular Engineering, North Carolina State University
2:30pm - 3:00pm
An innovative approach to address high aggregate challenges in engineered monoclonal antibodies using flow through chromatography
- Al de Leon - Manager, Thermo Fisher Scientific
1:55pm - 2:00pm
Chairperson's Remarks
- John Schiel, Ph.D. - Research Chemist, IBBR, National Institute of Standards and Technology
2:00pm - 2:30pm
Building a Framework for Technology Transfer for Late-Phase and Commercial Production
- Shawn Allwein - Vice President, Biologics CMC, Teva
2:30pm - 3:00pm
Chromatography modeling trends – the future of process development
- Jennifer Reichert - Account Development Manager, Cytiva
Showing 2 of 2 Streams
Recovery & Purification
Manufacturing Strategy & Bioprocessing 4.0
4:00pm - 4:30pm
From a bench-scale rAAV platform process to GMP manufacturing: a look at how Tangential Flow Filtration (TFF) robustness and scaling impact successful process transfer
- Tyler Kennedy - Scientist, Gene Delivery Process and Analytical Development, Bristol Myers Squibb
4:30pm - 5:00pm
Assessing the Impact of Cumulative Hold during Purification on the Stability of Recombinant Adeno-associate Viral Product
- Wenjun Di - Senior Scientist, Ultragenyx Pharmaceutical Inc.
4:00pm - 4:30pm
Best Practices in Implementing a Supplier Assessment Questionnaire
- Alanna Benamy - Manager, Member Engagement, Rx-360
4:30pm - 5:00pm
Big Ideas, Bold Goals, and the Future of Biomanufacturing
- John Schiel, Ph.D. - Research Chemist, IBBR, National Institute of Standards and Technology
Get the Latest Event Updates
Sign up to get the latest event updates and information.
Filter
Streams
Clear
Formats